Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04648696 · ClinicalTrials.gov registry record · Phase 4
Safety and Outcomes Associated With Continuous Versus Intermittent Infusion Vancomycin
A Phase 4 study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
NCT04648696 is a Phase 4 study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 8 participants.
The verdict
NCT04648696, a Phase 4 study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
Study Summary
Evaluate the safety and outcomes associated between the two treatment modalities
Interventions
- DRUG Vancomycin CI
- DRUG Vancomycin II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-03-03 |
| Est. Completion | 2022-10-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04648696
The ClinicalTrials.gov registry entry for NCT04648696 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vancomycin CI is the first listed.
NCT04648696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04648696 about?
NCT04648696 is a clinical study titled "Safety and Outcomes Associated With Continuous Versus Intermittent Infusion Vancomycin". Evaluate the safety and outcomes associated between the two treatment modalities
What is the current status of trial NCT04648696?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2021-03-03. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT04648696?
The interventions under investigation include: Vancomycin CI (DRUG), Vancomycin II (DRUG).
Who is sponsoring clinical trial NCT04648696?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.